Cutting through the weeds: Evaluation of a novel adsorption with crossmatch cells and elution protocol to sharpen HLA antibody identification by the single antigen bead assay
暂无分享,去创建一个
[1] R. Bray,et al. Out with the old, in with the new: Virtual versus physical crossmatching in the modern era , 2019, HLA.
[2] Robert A Bray,et al. (F)Utility of the physical crossmatch for living donor evaluations in the age of the virtual crossmatch. , 2018, Human immunology.
[3] R. Bray,et al. It's about time: The development and validation of a rapid optimized single antigen bead (ROB) assay protocol for LABScreen. , 2017, Human immunology.
[4] N. El-Awar,et al. HLA Epitopes: The Targets of Monoclonal and Alloantibodies Defined , 2017, Journal of immunology research.
[5] B. Shames,et al. Renal Transplantation With Final Allocation Based on the Virtual Crossmatch , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] S. Lepreux,et al. Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation , 2016, Transplantation.
[7] J. Moreau,et al. Deciphering allogeneic antibody response against native and denatured HLA epitopes in organ transplantation , 2015, European journal of immunology.
[8] C. Jacquelinet,et al. Denatured Class I Human Leukocyte Antigen Antibodies in Sensitized Kidney Recipients: Prevalence, Relevance, and Impact on Organ Allocation , 2014, Transplantation.
[9] R. Bray,et al. HLA Antibody Detection With Solid Phase Assays: Great Expectations or Expectations Too Great? , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] V. Thohan,et al. Practical value of identifying antibodies to cryptic HLA epitopes in cardiac transplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[11] D. Middleton,et al. Nothing's perfect: the art of defining HLA-specific antibodies. , 2014, Transplant immunology.
[12] M. Verhaar,et al. The significance of pretransplant donor‐specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation , 2013, Clinical and experimental immunology.
[13] M. Zeier,et al. Influence of Test Technique on Sensitization Status of Patients on the Kidney Transplant Waiting List , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] A. Webster,et al. Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation , 2013, Transplantation.
[15] M. Gandhi,et al. Positive virtual crossmatch with negative flow crossmatch results in two cases. , 2011, Transplant immunology.
[16] J. Cecka,et al. Calculated PRA: Initial Results Show Benefits for Sensitized Patients and a Reduction in Positive Crossmatches , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] P. Terasaki,et al. Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. , 2009, Human immunology.
[18] Junchao Cai,et al. Intact HLA Not &bgr;2m-free Heavy Chain-Specific HLA Class I Antibodies Are Predictive of Graft Failure , 2009, Transplantation.
[19] J. Steiger,et al. Clinical Relevance of Pretransplant Donor-Specific HLA Antibodies Detected by Single-Antigen Flow-Beads , 2009, Transplantation.
[20] P. Terasaki,et al. “Natural” Human Leukocyte Antigen Antibodies Found in Nonalloimmunized Healthy Males , 2008, Transplantation.
[21] D. Nochy,et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. , 2008, Contributions to nephrology.
[22] D. Nochy,et al. Clinical Relevance of Preformed HLA Donor‐Specific Antibodies in Kidney Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] P. Terasaki,et al. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens. , 2007, Human immunology.
[24] René J Duquesnoy,et al. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. , 2002, Human immunology.
[25] L. Lebeck,et al. The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities. , 1989, Transplantation.
[26] P. Russell,et al. Use of an antiglobulin-ATG reagent for detection of low levels of alloantibody-improvement of allograft survival in presensitized recipients. , 1978, Transplantation proceedings.
[27] F. Whittier,et al. A comparison of the antiglobulin versus extended incubation time crossmatch: results in 223 renal transplants. , 1977, Transplantation proceedings.
[28] P. Terasaki,et al. Significance of the positive crossmatch test in kidney transplantation. , 1969, The New England journal of medicine.
[29] D. B. Amos,et al. A simple micro cytotoxicity test. , 1969, Transplantation.
[30] H. Gebel,et al. Of Cells and Microparticles: Assets and Liabilities of HLA Antibody Detection. , 2018, Transplantation.
[31] David M. Conrad,et al. Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols. , 2018, Human immunology.
[32] H. Perkins,et al. Flow cytometry analysis: A high technology cross-match technique facilitating transplantation , 1983 .